Associated Papers
Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma.
Kuras M et al.
Cancers, 2025
A novel gain-of-function PIP4K2A mutation elevates the expression of β-globin and aggravates the severity of α-thalassemia.
Zhang Y et al.
British Journal of Haematology, 2023
Distribution and localization of phosphatidylinositol 5-phosphate, 4-kinase alpha and beta in the brain.
Noch EK et al.
The Journal of Comparative Neurology, 2021
Kv7 Channels and Excitability Disorders.
Jones F et al.
Handbook of Experimental Pharmacology, 2021
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia.
Fontana D et al.
Hemasphere, 2020
Genetic polymorphisms of PIP5K2A and course of schizophrenia.
Poltavskaya EG et al.
Bmc Medical Genetics, 2020
Characterizing rare and low-frequency height-associated variants in the Japanese population.
Akiyama M et al.
Nature Communications, 2019
PIP4K2A as a negative regulator of PI3K in PTEN-deficient glioblastoma.
Shin YJ et al.
The Journal of Experimental Medicine, 2019
PIP4K2A regulates intracellular cholesterol transport through modulating PI(4,5)P2 homeostasis.
Hu A et al.
Journal of Lipid Research, 2018
Association study indicates a protective role of phosphatidylinositol-4-phosphate-5-kinase against tardive dyskinesia.
Fedorenko OY et al.
The International Journal of Neuropsychopharmacology, 2014
The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data.
Tang X et al.
Nucleic Acids Research, 2014
Structural basis of PI(4,5)P2-dependent regulation of GluA1 by phosphatidylinositol-5-phosphate 4-kinase, type II, alpha (PIP5K2A).
Seebohm G et al.
Pflugers Archiv : European Journal of Physiology, 2014
Enzyme activity of the PIP4K2A gene product polymorphism that is implicated in schizophrenia.
Clarke JH et al.
Psychopharmacology, 2013
[Association of (N251S)-PIP5K2A with schizophrenic disorders: a study of the Russian population of Siberia].
Fedorenko OIu et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.s. Korsakova, 2013
PIP5K2A-dependent regulation of excitatory amino acid transporter EAAT3.
Fedorenko O et al.
Psychopharmacology, 2009
A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels.
Fedorenko O et al.
Psychopharmacology, 2008
Association study between genetic variants at the PIP5K2A gene locus and schizophrenia and bipolar affective disorder.
Jamra RA et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 2006
Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIalpha gene (PIP5K2A) with schizophrenia.
Schwab SG et al.
Molecular Psychiatry, 2006
Polymorphism screening of PIP5K2A: a candidate gene for chromosome 10p-linked psychiatric disorders.
Stopkova P et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 2003